Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells

被引:89
作者
de Totero, D
Meazza, R
Zupo, S
Cutrona, G
Matis, S
Colombo, M
Balleari, E
Pierri, I
Fabbi, M
Capaia, M
Azzarone, B
Gobbi, M
Ferrarini, M
Ferrini, S
机构
[1] Ist Nazl Ric Canc, Dept Translat Oncol & Med Oncol C, I-16132 Genoa, Italy
[2] Ist Giannina Gaslini, I-16148 Genoa, Italy
[3] Univ Genoa, Dept Hematol & Oncol, Genoa, Italy
[4] Hop Paul Brousse, INSERM, U542, Natl Sante & Rech Med, Villejuif, France
关键词
D O I
10.1182/blood-2005-09-3535
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-21 (IL-21) is a member of the IL-2 cytokine family, which mediates proliferation or growth arrest and apoptosis of normal B cells, depending on their activation state. Here we demonstrate that surface IL-21 receptor (R) is expressed at variable levels by chronic lymphocytic leukemia (CLL) B cells freshly isolated from 33 different patients. IL-21 R expression was up-regulated following cell stimulation via surface CD40. Therefore, IL-21 effects were more evident in CD40-activated CLL B cells. IL-21 induced an early signaling cascade in CLL B cells, which included JAK-1 and JAK-3 autophosphorylation and tyrosine phosphorylation of STAT-1, STAT-3, and STAT-5. IL-21 signaling failed to stimulate CLL B-cell proliferation, but induced their apoptosis. In addition, IL-21 counteracted the proliferative and antiapoptotic signals delivered by IL-15 to CLL B cells. IL-21-mediated apoptosis involved activation of caspase-8 and caspase-3, cleavage of Bid to its active form t-Bid, and cleavage of PARP and of p27Kip-1. Recent data indicate that CLL B cells require interaction with the microenvironment for their survival and expansion. The present findings thus provide a set of new mechanisms involved in the balance between cell-survival and apoptotic signals in CLL B cells.
引用
收藏
页码:3708 / 3715
页数:8
相关论文
共 53 条
[51]  
WANG G, 2000, CANCER RES, V15, P9016
[52]  
Wierda WG, 2000, BLOOD, V96, P2917
[53]   ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile [J].
Wiestner, A ;
Rosenwald, A ;
Barry, TS ;
Wright, G ;
Davis, RE ;
Henrickson, SE ;
Zhao, H ;
Ibbotson, RE ;
Orchard, JA ;
Davis, Z ;
Stetler-Stevenson, M ;
Raffeld, M ;
Arthur, DC ;
Marti, GE ;
Wilson, WH ;
Hamblin, TJ ;
Oscier, DG ;
Staudt, LM .
BLOOD, 2003, 101 (12) :4944-4951